United Mitochondrial Disease Foundation Names Kristen Clifford New President & CEO
The United Mitochondrial Disease Foundation (UMDF) Board of Trustees has named Kristen Clifford the organization’s next President and Chief...
Read moreThe United Mitochondrial Disease Foundation (UMDF) Board of Trustees has named Kristen Clifford the organization’s next President and Chief...
Read moreSign-up to receive the UMDF newsletter via email at Newsletter Signup. Mitochondrial Medicine 2025Call For Abstracts Now OpenUMDF's Call...
Read moreSign-up to receive the UMDF newsletter via email at Newsletter Signup. The Mito Fund Announces Investment in Khondrion UMDF’s venture...
Read moreThe United Mitochondrial Disease Foundation’s (UMDF) venture philanthropy arm, The Mito Fund, has invested in Khondrion, a Netherlands-based...
Read moreWith the recent election results, we’ve been getting some inquiries about the impact of a second Trump Administration on mitochondrial disease...
Read moreUMDF Cosigns Letter to Congress Encouraging End-of-Year Action on Accelerating Kids’ Access to Care Act, Rare Pediatric Disease Priority Review...
Read moreSign-up to receive the UMDF newsletter via email at Newsletter Signup. In early October, an FDA Advisory Committee voted 10-6 supporting...
Read moreFDA Advisory Committee Deems Potential Barth Syndrome Drug “Effective” Earlier this month, an FDA Advisory Committee voted 10-6...
Read moreAfter a full day of testimony that consistently demonstrated the need and efficacy of elamipretide for the treatment of Barth Syndrome, an FDA...
Read more